Sale

Periodontal Therapeutics Market

Global Periodontal Therapeutics Market Size, Share, Report: By Product: Systemic Antibiotics, Local Antibiotics; By Treatment Type: Non-Surgical Treatment, Surgical Treatment; By Disease Type: Gingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Global Periodontal Therapeutics Market Outlook

The global periodontal therapeutics market size attained a value of USD 3.07 billion in 2023, driven by growing incidence of diabetes. The market is anticipated to grow at a CAGR of 8.7% during the forecast period of 2024-2032 to attain a value of USD 6.49 billion by 2032.

 

Global Periodontal Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Segmentation

Periodontal diseases that trigger the destruction of the dentition supporting structures are prevalent chronic oral cavity infectious diseases. The periodontal therapeutics market can be divided on the basis of segments like products and distribution channels.

The periodontal therapeutics market can be divided on the basis of its product as systemic antibiotics and local antibiotics. Systemic antibiotics are further subdivided into doxycycline, minocycline, and metronidazole. Local antibiotics are also further subdivided into Arestin, Atridox, and PerioChip.

 

Global Periodontal Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The periodontal therapeutics market can be broadly categorised based on its distribution channel into:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • E-commerce

The EMR report looks into the regional markets of periodontal therapeutics like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Market Analysis

The growing incidence of diabetes is driving the global periodontal therapeutics market. Due to product affordability, accessibility, and elevated industry penetration, systemic antibiotics held the most significant share in the periodontal therapeutics market. They would further drive the periodontal therapeutics market growth during the forecast period. The rising incidence of periodontal diseases owing to a sedentary lifestyle, an effective reimbursement scenario, and an increasing geriatric population are the key drivers for the growth of the North American market for periodontal therapeutics.

 

Global Periodontal Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global periodontal therapeutics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • 3M Company        
  • Den-Mat Holdings, LLC  
  • Dexcel Ltd.
  • Kaken Pharmaceutical Co., Ltd.      
  • Bausch Health Companies Inc.
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Treatment Type
  • Disease Type
  • End User
  • Region
Breakup by Product
  • Systemic Antibiotics
  • Local Antibiotics
Breakup by Treatment Type
  • Non-Surgical Treatment
  • Surgical Treatment
Breakup by Disease Type
  • Gingivitis
  • Chronic Periodontal Disease
  • Aggressive Periodontal Disease
  • Others
Breakup by End User
  • Hospitals
  • Dental Clinics
  • Dental Academics and Research Institutes
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • 3M Company
  • Den-Mat Holdings, LLC
  • Dexcel Pharma
  • Kaken Pharmaceutical Co., Ltd.
  • Bausch Health Companies Inc.
  • Colgate-Palmolive Company (India) Limited
  • Mylan N.V.
  • WOCKHARDT
  • Pfizer Inc
  • Noveome Biotherapeutics, Inc
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Periodontal Disease Overview

    3.1    Guidelines and Stages
    3.2    Pathophysiology
    3.3    Screening and Diagnosis
    3.4    Treatment Pathway 
4    Patient Profile
    4.1    Patient Profile Overview
    4.2    Patient Psychology and Emotional Impact Factors
    4.3    Risk Assessment and Treatment Success Rate
5    Periodontal Disease Epidemiology Analysis
    5.1    Epidemiology Overview (2016-2031)
    5.2    North America Periodontal Disease Epidemiology (2016-2031)
    5.3    Europe Periodontal Disease Epidemiology (2016-2031)
    5.4    Asia-Pacific Periodontal Disease Epidemiology (2016-2031)
    5.5    Latin America Periodontal Disease Epidemiology (2016-2031)
    5.6    Middle East & Africa Periodontal Disease Epidemiology (2016-2031)
6    Global Periodontal Therapeutics Market Overview 
    6.1    Global Periodontal Therapeutics Market Historical Value (2017-2023) 
    6.2    Global Periodontal Therapeutics Market Forecast Value (2024-2032)
7    Global Periodontal Therapeutics Market Landscape
    7.1    Periodontal Therapeutics: Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
    7.2    Periodontal Therapeutics: Product Landscape
        7.2.1    Analysis by Product
        7.2.2    Analysis by Treatment 
        7.2.3    Analysis by Disease Type
        7.2.4    Analysis by End User
8    Periodontal Therapeutics Challenges and Unmet Needs
    8.1    Treatment Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Cost of Treatment
10    Global Periodontal Therapeutics Market Dynamics

    10.1    Market Drivers and Constraints
    10.2    SWOT Analysis
    10.3    Porter’s Five Forces Model
    10.4    Key Demand Indicators 
    10.5    Key Price Indicators
    10.6    Industry Events, Initiatives, and Trends  
    10.7    Value Chain Analysis
11    Global Periodontal Therapeutics Market Segmentation
    11.1    Global Periodontal Therapeutics Market by Product
        11.1.1    Market Overview
        11.1.2    Systemic Antibiotics
        11.1.3    Local Antibiotics
    11.2    Global Periodontal Therapeutics Market by Treatment Type
        11.2.1    Market Overview
        11.2.2    Non-Surgical Treatment
        11.2.3    Surgical Treatment
    11.3    Global Periodontal Therapeutics Market by Disease Type
        11.3.1    Market Overview
        11.3.2    Gingivitis
        11.3.3    Chronic Periodontal Disease
        11.3.4    Aggressive Periodontal Disease
        11.3.5    Others
    11.4    Global Periodontal Therapeutics Market by End User
        11.4.1    Market Overview
        11.4.2    Hospitals 
        11.4.3    Dental Clinics
        11.4.4    Dental Academics and Research Institutes
        11.4.5    Others
    11.5    Global Periodontal Therapeutics Market by Region
        11.5.1    Market Overview
        11.5.2    North America
        11.5.3    Europe 
        11.5.4    Asia Pacific
        11.5.5    Latin America
        11.5.6    Middle East and Africa
12    North America Periodontal Therapeutics Market
    12.1    Market Share by Country
    12.2    United States of America
    12.3    Canada
13    Europe Periodontal Therapeutics Market
    13.1    Market Share by Country
    13.2    United Kingdom
    13.3    Germany
    13.4    France
    13.5    Italy
    13.6    Others
14    Asia Pacific Periodontal Therapeutics Market
    14.1    Market Share by Country
    14.2    China
    14.3    Japan
    14.4    India
    14.5    ASEAN
    14.6    Australia
    14.7    Others
15    Latin America Periodontal Therapeutics Market
    15.1    Market Share by Country
    15.2    Brazil
    15.3    Argentina
    15.4    Mexico
    15.5    Others
16    Middle East and Africa Periodontal Therapeutics Market
    16.1    Market Share by Country
    16.2    Saudi Arabia
    16.3    United Arab Emirates
    16.4    Nigeria
    16.5    South Africa
    16.6    Others
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Patent Analysis
    18.1    Analysis by Type of Patent
    18.2    Analysis by Publication year
    18.3    Analysis by Issuing Authority
    18.4    Analysis by Patent Age
    18.5    Analysis by CPC Analysis
    18.6    Analysis by Patent Valuation 
    18.7    Analysis by Key Players
19    Grants Analysis
    19.1    Analysis by year
    19.2    Analysis by Amount Awarded
    19.3    Analysis by Issuing Authority
    19.4    Analysis by Grant Application
    19.5    Analysis by Funding Institute
    19.6    Analysis by NIH Departments
    19.7    Analysis by Recipient Organization 
20    Clinical Trials Analysis
    20.1     Analysis by Trial Registration Year
    20.2    Analysis by Trial Status
    20.3    Analysis by Trial Phase
    20.4    Analysis by Therapeutic Area
    20.5    Analysis by Geography
21    Funding and Investment Analysis
    21.1    Analysis by Funding Instances
    21.2    Analysis by Type of Funding
    21.3    Analysis by Funding Amount
    21.4    Analysis by Leading Players
    21.5    Analysis by Leading Investors
    21.6    Analysis by Geography
22    Partnership and Collaborations Analysis
    22.1    Analysis by Partnership Instances
    22.2    Analysis by Type of Partnership
    22.3    Analysis by Leading Players
    22.4    Analysis by Geography
23    Supplier Landscape
    23.1    3M Company
        23.1.1    Financial Analysis
        23.1.2    Product Portfolio
        23.1.3    Demographic Reach and Achievements
        23.1.4    Mergers and Acquisitions
        23.1.5    Certifications
    23.2    Den-Mat Holdings, LLC
        23.2.1    Financial Analysis
        23.2.2    Product Portfolio
        23.2.3    Demographic Reach and Achievements
        23.2.4    Mergers and Acquisitions
        23.2.5    Certifications
    23.3    Dexcel Pharma
        23.3.1    Financial Analysis
        23.3.2    Product Portfolio
        23.3.3    Demographic Reach and Achievements
        23.3.4    Mergers and Acquisitions
        23.3.5    Certifications
    23.4    Kaken Pharmaceutical Co., Ltd.
        23.4.1    Financial Analysis
        23.4.2    Product Portfolio
        23.4.3    Demographic Reach and Achievements
        23.4.4    Mergers and Acquisitions
        23.4.5    Certifications
    23.5    Bausch Health Companies Inc.
        23.5.1    Financial Analysis
        23.5.2    Product Portfolio
        23.5.3    Demographic Reach and Achievements
        23.5.4    Mergers and Acquisitions
        23.5.5    Certifications
    23.6    Colgate-Palmolive Company (India) Limited
        23.6.1    Financial Analysis
        23.6.2    Product Portfolio
        23.6.3    Demographic Reach and Achievements
        23.6.4    Mergers and Acquisitions
        23.6.5    Certifications
    23.7    Mylan N.V.
        23.7.1    Financial Analysis
        23.7.2    Product Portfolio
        23.7.3    Demographic Reach and Achievements
        23.7.4    Mergers and Acquisitions
        23.7.5    Certifications
    23.8    WOCKHARDT
        23.8.1    Financial Analysis
        23.8.2    Product Portfolio
        23.8.3    Demographic Reach and Achievements
        23.8.4    Mergers and Acquisitions
        23.8.5    Certifications
    23.9    Pfizer Inc
        23.9.1    Financial Analysis
        23.9.2    Product Portfolio
        23.9.3    Demographic Reach and Achievements
        23.9.4    Mergers and Acquisitions
        23.9.5    Certifications
    23.10    Noveome Biotherapeutics, Inc
        23.10.1    Financial Analysis
        23.10.2    Product Portfolio
        23.10.3    Demographic Reach and Achievements
        23.10.4    Mergers and Acquisitions
        23.10.5    Certifications
24    Periodontal Therapeutics - Distribution Model (Additional Insight)
    24.1    Overview 
    24.2    Potential Distributors 
    24.3    Key Parameters for Distribution Partner Assessment 
25    Key Opinion Leaders (KOL) Insights (Additional Insight)
26    Company Competitiveness Analysis (Additional Insight)

    26.1    Very Small Companies
    26.2    Small Companies
    26.3    Mid-Sized Companies
    26.4    Large Companies
    26.5    Very Large Companies
27    Payment Methods (Additional Insight)
    27.1    Government Funded
    27.2    Private Insurance
    27.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2023, the global market periodontal therapeutics attained a value of USD 3.07 billion.

The market is anticipated to grow at a CAGR of 8.7% during the forecast period of 2024-2032 to reach a value of USD 6.49 billion by 2032.

The rising incidence of diabetes along with the affordability and accessibility of the therapeutic products and services are the major driver for the global market.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America has been leading the global market.

The products in the market include systemic antibiotics and local antibiotics.

The treatment types include non-surgical treatment and surgical treatment.

The disease types can be categorised into gingivitis, chronic periodontal disease, and aggressive periodontal disease, among others.

The end-users include hospitals, dental clinics, dental academics and research institutes, among others.

Key players involved in the market are 3M Company, Den-Mat Holdings, LLC, Dexcel Pharma, Kaken Pharmaceutical Co., Ltd., Bausch Health Companies Inc., Colgate-Palmolive Company (India) Limited, Mylan N.V., Pfizer Inc, Noveome Biotherapeutics, Inc., and WOCKHARDT.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER